Conduit Fund
20-21 Tooks Court, Cursitor Street, London, EC4A 1BD, United Kingdom
Overview
Sustainable growth in any modern economy is dependent upon the ability to deliver reliable, cost competitive and environmentally sustainable energy and water. Across the world increased water demand from rapid urbanisation and climate change is placing considerable stress on supplies. Businesses, municipalities and industries are recognizing that water quality and supply cannot be taken for granted. As more recent events have demonstrated, security of supply of fresh water is not only critical for human consumption but also for production and profitability of several industries. Industries and governments are increasingly adopting a strategic approach to water usage and management in order to maximize efficiency and to mitigate the risk of disruption which could arise from shortages and/or changes to quality. The investment opportunities are extraordinary because many new materials and technologies are reshaping the power, water and energy industries to meet increasing demand. Most of this demand is coming from transition economies where growth is rapid. For example, in optimization solutions which address energy efficiency (including up-and-downstream processes in the oil & gas and power sectors) and the substitution that provides reliable low carbon alternatives, significant benefits are currently being generated from incremental advancements in technologies. The future of energy is one of innovation and technology deployment which results in changes; and changes provide opportunities. They have historically invested in critical points along the value chain in collaboration with their strategic alliance partners in order to deliver credible business solutions in key growth markets. This augments their extensive experience and network in deploying technology solutions into the market.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 2
Sector focus
- Energy
- Finance
- Venture Capital
Investment portfolio
- Perci Health
Participated · Equity · Jun 2025
Perci Health operates an AI-powered, multidisciplinary virtual cancer clinic that integrates digital tools with NHS-trained specialist clinicians to deliver personalised cancer prevention, treatment navigation, symptom management and survivorship care. The company has a network of over 85 NHS-trained specialists and emphasizes a predominantly female leadership and board. Founded in 2020, Perci aims to expand its virtual clinic across the UK and deepen partnerships with insurers, employers, the NHS and charities to improve outcomes and reduce costs. The new funding is intended to scale the platform’s reach to more individuals and healthcare providers and to support programmes such as personalised recovery and return-to-work interventions. Perci highlights measurable clinical and cost-efficiency impacts as part of its case for broader adoption across health systems. Perci Health operates a specialized digital platform that connects people living with and beyond cancer, and their caregivers, to vetted cancer professionals through personalized programs. The platform covers the full cancer continuum, from preparing for treatment to support during treatment, recovery, rehabilitation and return to work. Programs are delivered digitally and tailored to individual needs. The company intends to use new funding to further invest in its technology roadmap, continue to expand the team and grow access through new partnerships. Perci recently closed a Seed round to support these plans. Perci Health claims to be the world’s first online platform giving people access to support from multidisciplinary cancer teams. The service connects clients with vetted cancer professionals — dietitians, physiotherapists, psychologists, sexual medicine practitioners — all with a minimum of three years of cancer experience. Users can browse trusted articles, book a free session with a Perci Expert (trained cancer nurses), and receive a personalised care plan that can be shared with their medical team. The startup emphasizes evidence-based, research-backed care rather than alternative therapies and is governed by leading UK oncologists and cancer surgeons. Perci’s mission is to make affordable, high-quality cancer care more accessible and to challenge the status quo for people living with and beyond cancer. The company launched with seed funding to support its growth and service rollout.
Team
John Butt
General Partner
LinkedInDavid Lawrence
General Partner